We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AUPH

Price
12.12
Stock movement down
-0.10 (-0.82%)
Company name
Aurinia Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.60B
Ent value
1.72B
Price/Sales
7.24
Price/Book
4.11
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
15.91
PEG
-
EPS growth
-6.35%
1 year return
67.40%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

AUPH does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF54.81
Price to FCF55.33
Price to EBITDA422.39
EV to EBITDA455.27

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales7.24
Price to Book4.11
EV to Sales7.80

FINANCIALS

Per share

Loading...
Per share data
Current share count131.63M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)0.84

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash73.19M
Net receivables30.93M
Total current assets438.74M
Goodwill0.00
Intangible assets3.90M
Property, plant and equipment0.00
Total assets527.53M
Accounts payable2.21M
Short/Current long term debt78.21M
Total current liabilities76.22M
Total liabilities161.76M
Shareholder's equity365.77M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open12.10
Daily high12.30
Daily low11.96
Daily Volume1.17M
All-time high33.08
1y analyst estimate14.17
Beta1.46
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AUPHS&P500
Current price drop from All-time high-63.36%-1.10%
Highest price drop-79.59%-19.00%
Date of highest drop9 Oct 20248 Apr 2025
Avg drop from high-72.51%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
AUPH (Aurinia Pharmaceuticals Inc) company logo
Marketcap
1.60B
Marketcap category
Small-cap
Description
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
Employees
130
Investor relations
-
SEC filings
CEO
Peter S. Greenleaf
Country
USA
City
Victoria
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...